Myriocin, also known as antibiotic ISP-1 and thermozymocidin, is a non-proteinogenic amino acid derived from the entomopathogenic fungus, Isaria sinclairii.[1]
Names | |
---|---|
Systematic IUPAC name
(2S,3R,4R,6E)-2-Amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid | |
Other names
Antibiotic ISP-1; Thermozymocidin
| |
Identifiers | |
3D model (JSmol)
|
|
5113331 | |
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.164.620 |
KEGG | |
PubChem CID
|
|
RTECS number |
|
UNII | |
UN number | 2811 |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C21H39NO6 | |
Molar mass | 401.54 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Myriocin is a very potent inhibitor of serine palmitoyltransferase, the first step in sphingosine biosynthesis.[1] Due to this property, it is used in biochemical research as a tool for depleting cells of sphingolipids.
Myriocin was shown to inhibit the proliferation of an IL-2-dependent mouse cytotoxic T cell line.[citation needed]
Myriocin possesses immunosuppressant activity. It is reported to be 10- to 100-fold more potent than ciclosporin.[citation needed]
The multiple sclerosis drug fingolimod was derived from myriocin by using structure–activity relationship studies to determine the parts of the molecule important to its activity.[citation needed]